(1 - 13 von 14
)
EMBL-Cancer Core Europe Conference - Cancer Immunotherapy - Programme
www.embl.de
Thomas Blankenstein, Max-Delbrück Center for Molecular Medicine. 15:45-16:15: Coffee Break. 16:15-16:45: Robert Schreiber, Washington University School of Medicine.
Medigene : Academic Partners Provide Update on Planned...
www.marketscreener.com
Planegg - Medigene AG , announced that researchers from Max-Delbrück-Center for Molecular Medicine and Charité, both in Berlin, Germany, will present an...
sortiert nach Relevanz / Datum